Fulgent Genetics FLGT
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$1.43M (4 inflow days, 16 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 50.7% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 9.29% to 7.33% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| BlackRock | Mutual Fund | 2026/Q3 | +153,119 | 8.7% |
| BNP Paribas Financial Markets SNC | Private Company | 2026/Q3 | +78,052 | 0.5% |
| Acadian Asset Management LLC | Mutual Fund | 2026/Q3 | +73,038 | 3.9% |
| Morgan Stanley | Public Company | 2026/Q3 | +38,132 | 0.7% |
| Morgan Stanley Investment Management Inc. | Mutual Fund | 2026/Q3 | +38,132 | 0.7% |
| Jacobs Levy Equity Management Inc | Mutual Fund | 2026/Q3 | +425,757 | 2.8% |
| Diametric Capital, LP | Hedge Fund | 2026/Q3 | +336,738 | 2.5% |
| JPMorgan Chase & Co. | Public Company | 2026/Q3 | +298,416 | 2.6% |
| Point72 Asset Management, L.P. | Hedge Fund | 2026/Q3 | +211,708 | 0.8% |
| Hudson River Trading LLC | Private Company | 2026/Q3 | +182,996 | 0.8% |
| Citadel Advisors LLC | Hedge Fund | 2026/Q3 | +121,232 | 0.6% |
| Columbia Management Investment Advisers, LLC | Mutual Fund | 2026/Q3 | +106,709 | 2.4% |
| Goldman Sachs Asset Management, L.P. | Mutual Fund | 2026/Q3 | +103,892 | 0.5% |
| Two Sigma Investments, LP | Hedge Fund | 2026/Q3 | +78,797 | 1.4% |
| Levin Capital Strategies, L.P. | Mutual Fund | 2026/Q3 | +62,308 | 0.4% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 25 Oct 2026 | Paul Kim | Chief Financial Officer | Sale to Issuer | -2,748 | $20.22 | 353,795 |
| 25 Oct 2026 | Hanlin Gao | Chief Scientific Officer & Lab Director | Sale to Issuer | -1,645 | $20.22 | 984,472 |
| 25 Oct 2026 | Jian Xie | Chief Operating Officer | Sale to Issuer | -4,361 | $20.22 | 576,379 |
| 1 Sep 2026 | Hanlin Gao | Chief Scientific Officer & Lab Director | Open Market Disposition | -1,673 | $19.66 | 986,117 |
| 1 Sep 2026 | Jian Xie | Chief Operating Officer | Open Market Disposition | -2,127 | $19.66 | 580,740 |
| 31 Aug 2026 | Paul Kim | Chief Financial Officer | Sale to Issuer | -2,087 | $19.59 | 356,543 |
| 31 Aug 2026 | Ming Hsieh | Chairperson & CEO | Sale to Issuer | -4,392 | $19.59 | 8,874,487 |
| 26 Aug 2026 | Hanlin Gao | Chief Scientific Officer & Lab Director | Open Market Disposition | -939 | $19.91 | 987,790 |
| 26 Aug 2026 | Jian Xie | Chief Operating Officer | Open Market Disposition | -1,193 | $19.91 | 582,867 |
| 25 Aug 2026 | Paul Kim | Chief Financial Officer | Sale to Issuer | -1,168 | $19.81 | 358,630 |
| 25 Aug 2026 | Ming Hsieh | Chairperson & CEO | Sale to Issuer | -2,949 | $19.81 | 8,870,694 |
| 25 Jul 2026 | Paul Kim | Chief Financial Officer | Sale to Issuer | -2,747 | $19.67 | 359,798 |
| 25 Jul 2026 | Hanlin Gao | Chief Scientific Officer & Lab Director | Sale to Issuer | -1,645 | $19.67 | 988,729 |
| 25 Jul 2026 | Jian Xie | Chief Operating Officer | Sale to Issuer | -4,361 | $19.67 | 584,060 |
| 1 Jun 2026 | Hanlin Gao | Chief Scientific Officer & Lab Director | Open Market Disposition | -1,688 | $17.89 | 990,374 |
| 1 Jun 2026 | Jian Xie | Chief Operating Officer | Open Market Disposition | -2,146 | $17.89 | 588,421 |
| 31 May 2026 | Paul Kim | Chief Financial Officer | Sale to Issuer | -2,087 | $18.09 | 362,545 |
| 31 May 2026 | Ming Hsieh | Chairperson & CEO | Sale to Issuer | -4,392 | $18.09 | 8,868,147 |
| 26 May 2026 | Hanlin Gao | Chief Scientific Officer & Lab Director | Open Market Disposition | -945 | $17.60 | 992,062 |
| 26 May 2026 | Jian Xie | Chief Operating Officer | Open Market Disposition | -1,201 | $17.60 | 590,567 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 2,017,619 | 7.3% | 7.8 |
| 15 Oct 2026 | 2,132,685 | 7.8% | 7.4 |
| 30 Sep 2026 | 2,238,210 | 8.1% | 7.2 |
| 15 Sep 2026 | 2,318,058 | 8.4% | 6.7 |
| 31 Aug 2026 | 2,368,385 | 8.6% | 10.0 |
| 14 Aug 2026 | 2,555,609 | 9.3% | 9.3 |
No comments yet — be the first to weigh in on FLGT.
Sign in to join the discussion.